Back to search

Article

Diosgenin Inhibits Prostate Cancer Progression by Inducing UHRF1 Protein Degradation

2022-05-12

Abstract excerpt

<h4>Background: </h4> and Purpose: Aberrant overexpression of UHRF1 has been reported in several cancer types and UHRF1 is regarded as a novel drug target for cancer therapy. However, no UHRF1-targeted specific small compound inhibitor has been registered in clinical trials. Experimental Approach: Network pharmacology together with molecular docking were used to screened a natural molecule bank for PCa treatment....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8873950d-e8c9-5ba6-9fd0-e516aeab3c63
DOI
10.22541/au.165237524.42526501/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Diosgenin Inhibits Prostate Cancer Progression by Inducing UHRF1 Protein DegradationDOI 10.22541/au.165237524.42526501/v1
Select a neighboring publication to make it the new centre.